Search for: "ASTRAZENECA LP"
Results 21 - 40
of 138
Sort by Relevance
|
Sort by Date
21 Dec 2015, 5:43 pm
” AstraZeneca LP v. [read post]
18 Dec 2015, 9:19 am
AstraZeneca Pharm. [read post]
17 Dec 2015, 11:54 am
Patents in his portfolio include US Patent Numbers 6,331,400, 6,771,291, 7,353,199, 7,996,259, 8,335,713, 8,412,570, 8,417,567, 8,423,399, 8,442,860, 8,589,222, 8,650,076, 8,768,760, 8,781,890 and 8,996,398.[8] = = = = = [1] US patent Application No. 10/868,312, claim number 24. [2] See 1 Chisum on Patents section 1.02. [3] In re Russell, 48 F.2d 668, 669 (CCPA 1931)(indexing the names in directories and dictionaries). [4] AstraZeneca LP v. [read post]
8 Dec 2015, 2:22 pm
AstraZeneca LP and Cephalon Inc. paid the United States $26.7 million and $4.3 million, respectively, in separate settlements for allegedly underpaying rebates owed under the Medicaid Drug Rebate Program. [read post]
9 Sep 2015, 6:11 am
The Department of Justice announced settlements in the following False Claims Act lawsuits: AstraZeneca and Cephalon to Pay $46.5 Million and $7.5 Million, Respectively, for Allegedly Underpaying Rebates Owed Under Medicaid Drug Rebate Program AstraZeneca LP has agreed to pay the United States and participating states a total of $46.5 million, plus interest, to resolve allegations that it knowingly underpaid rebates owed under the Medicaid Drug Rebate Program, the Justice… [read post]
27 Feb 2015, 5:02 am
AstraZeneca to Pay $7.9 Million to Resolve Kickback Allegations AstraZeneca LP, a pharmaceutical manufacturer based in Delaware, agreed to pay the government $7.9 million to settle allegations that it engaged in a kickback scheme in violation of the False Claims Act. [read post]
13 Feb 2015, 12:00 pm
AstraZeneca LP et al. was filed under seal on behalf of the federal government in October 2010 by former AstraZeneca employees Paul DiMattia and F. [read post]
13 Nov 2014, 5:00 am
Courtesy of Mike Imbroscio of Covington (who was on the winning team) today’s post is about a very satisfying Cymbalta win – not only did warning causation fail under the learned intermediary rule, but the warning for the drug was held adequate as a matter of law. [read post]
23 Jun 2014, 12:57 pm
ITERATIVE DISJUNCTIVE SYLLOGISM Basic propositional logic teaches that the disjunctive syllogism (modus tollendo ponens) is a valid argument, in which one of its premises is a disjunction (P v Q), and the other premise is the negation of one of the disjuncts: P v Q ~P_____ ∴ Q See Irving Copi & Carl Cohen Introduction to Logic at 362 (2005). [read post]
3 May 2014, 8:56 am
After a long winter, the cherry trees are finally managing to blossom. [read post]
23 Apr 2014, 7:44 am
” See also AstraZeneca LP v. [read post]
19 Sep 2013, 9:53 am
The following post is exclusively the work of the Reed Smith side of the blog.Sometimes the smallest, least significant type of lawsuit can illustrate cracks in the edifice of the largest, most consequential litigation. [read post]
14 Aug 2013, 1:57 pm
We’ve already provided our readers with our list of the testimony (trial and deposition) of the seemingly ubiquitous plaintiff’s expert Dr. [read post]
19 Jul 2013, 10:43 am
AstraZeneca Pharms. [read post]
4 Jun 2013, 11:22 am
Guinn v AstraZeneca Pharms. [read post]
14 May 2013, 6:18 pm
The lawsuits in the Nexium MDL claim that Nexium, created by manufacturer, AstraZeneca LP, causes side effects such as bone loss, which subsequently has resulted in fractures and similar symptoms. [read post]
27 Feb 2013, 9:53 pm
LP v. [read post]
30 Nov 2012, 7:45 am
No. 10-915-LPS (D. [read post]
29 Nov 2012, 5:21 am
No. 10-915-LPS (D. [read post]
10 Sep 2012, 7:28 pm
In July, after a court battle with FDA that started around mid-March when AstraZeneca Pharmaceuticals LP (“AstraZeneca”) sought to enjoin FDA from granting final ANDA approvals for generic SEROQUEL following FDA’s denial (without comment) of two citizen petitions AstraZeneca submitted to FDA last year concerning labeling carve-out issues, the U.S. [read post]
